E2086
- Generic Name
- E2086
A Study of E2086 in Healthy Adult Participants
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT06481488
- Locations
- 🇺🇸
Parexel International, Glendale, California, United States
A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1
Phase 1
Completed
- Conditions
- Narcolepsy Type 1 (NT1)
- Interventions
- First Posted Date
- 2024-06-17
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT06462404
- Locations
- 🇺🇸
SDS Clinical Trials, Santa Ana, California, United States
🇺🇸PharmaDev Clinical Research, Miami, Florida, United States
🇺🇸Sleep Practioners, LLC, Macon, Georgia, United States
A Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2086 in Healthy Adult and Elderly Participants
- First Posted Date
- 2023-02-27
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 53
- Registration Number
- NCT05745207
- Locations
- 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath